AIDS Home > Liposomal Doxorubicin Information

Liposomal doxorubicin (Doxil®) is a prescription chemotherapy drug that is approved for treating ovarian cancer, multiple myeloma, and AIDS-related Kaposi's sarcoma. It is a liposomal formulation of doxorubicin, which means that the medication is contained in tiny fatty bubbles. This product comes in injectable form and is typically given every three to four weeks.
Liposomal doxorubicin is not appropriate for everyone; your healthcare provider needs complete information on your medical history and what medicines you are taking to make sure this type of chemotherapy is right for you. Some of the most common side effects of liposomal doxorubicin include:
  • Nausea
  • Low blood platelets (thrombocytopenia)
  • Anemia
  • Hand-foot syndrome (pain, redness, and swelling of the palms and soles).
(For more information, click Liposomal Doxorubicin. This article provides an in-depth overview of this chemotherapy medication, with details on how it works, what to expect during treatment, what to discuss with your healthcare provider, and more.)
Written by/reviewed by:
Last reviewed by: Arthur Schoenstadt, MD
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation

Topics & Medications


Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.